ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $1 | $7 | $0 |
| SG&A Expenses | $5 | $1 | $7 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $1 | $7 | $0 |
| Operating Income | -$5 | -$1 | -$7 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $2 | $0 | $0 |
| Pre-Tax Income | -$2 | $1 | -$7 | -$0 |
| Tax Expense | $0 | -$2 | $0 | $0 |
| Net Income | -$2 | $1 | -$7 | -$0 |
| % Margin | – | – | – | – |
| EPS | -0.22 | 0.16 | -0.4 | -0.001 |
| % Growth | -237.5% | 140% | -57,042.9% | – |
| EPS Diluted | -0.22 | 0.16 | -0.4 | -0.001 |
| Weighted Avg Shares Out | 10 | 19 | 17 | 19 |
| Weighted Avg Shares Out Dil | 10 | 19 | 17 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $1 | $0 | $0 |
| EBITDA | -$5 | -$1 | $0 | -$0 |
| % Margin | – | – | – | – |